Evidence map›Paper›PMID 35869996›Full record

ArticleJournal of neurology2022

Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study.

T Bogdan, T Wirth, A Iosif, A Schalk, S Montaut, C Bonnard, G Carre, O Lagha-Boukbiza, C Reschwein, E Albugues and 21 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 1 country.

T Bogdan *Neurology Department, Strasbourg University Hospital, Strasbourg, France. thomas.bogdan@chru-strasbourg.fr.ORCID http://orcid.org/0000-0002-8627-4904
T Wirth *Neurology Department, Strasbourg University Hospital, Strasbourg, France.
A IosifNeurology Department, Strasbourg University Hospital, Strasbourg, France.
A SchalkStrasbourg Federation of Translational Medicine (FMTS), Strasbourg University, Strasbourg, France.
S MontautNeurology Department, Strasbourg University Hospital, Strasbourg, France.
C BonnardNeurology Department, Strasbourg University Hospital, Strasbourg, France.
G CarreNeurology Department, Strasbourg University Hospital, Strasbourg, France.
O Lagha-BoukbizaNeurology Department, Strasbourg University Hospital, Strasbourg, France.
C ReschweinNeurology Department, Strasbourg University Hospital, Strasbourg, France.
E AlbuguesNeurology Department, Strasbourg University Hospital, Strasbourg, France.
S DemuthNeurology Department, Strasbourg University Hospital, Strasbourg, France.
H LandsbergerNeurology Department, Strasbourg University Hospital, Strasbourg, France.
M EinsiedlerNeurology Department, Strasbourg University Hospital, Strasbourg, France.
T ParratteNeurology Department, Strasbourg University Hospital, Strasbourg, France.
A NguyenNeurology Department, Strasbourg University Hospital, Strasbourg, France.
F LamyNeurology Department, Strasbourg University Hospital, Strasbourg, France.
H DurandNeurology Department, Strasbourg University Hospital, Strasbourg, France.
P FahrerNeurology Department, Strasbourg University Hospital, Strasbourg, France.
P VoulleminotNeurology Department, Strasbourg University Hospital, Strasbourg, France.
K BigautNeurology Department, Strasbourg University Hospital, Strasbourg, France.
J B ChansonNeurology Department, Strasbourg University Hospital, Strasbourg, France.
G NicolasDepartment of Genetics and CNRMAJ, FHU G4 Génomique, Normandie Univ, UNIROUEN, Inserm U1245 and CHU Rouen, 76000, Rouen, France.
J ChellyLaboratory of Genetic Diagnosis, IGMA, Strasbourg University Hospital, Strasbourg, France.
C CazeneuveNeurogenetics Laboratory, Department of Genetics, APHP, University Hospital Pitié-Salpêtrière, Paris, France.
M KoenigLaboratory of Molecular Genetics, Montpellier University Hospital, Montpellier, France.
C BundDepartment of Nuclear Medicine, Strasbourg University Hospital, Strasbourg, France.
I J NamerDepartment of Nuclear Medicine, Strasbourg University Hospital, Strasbourg, France.
S KremerDepartment of Radiology, Strasbourg University Hospital, Strasbourg, France.
N CalmelsLaboratory of Genetic Diagnosis, IGMA, Strasbourg University Hospital, Strasbourg, France.
C TranchantNeurology Department, Strasbourg University Hospital, Strasbourg, France.
M AnheimNeurology Department, Strasbourg University Hospital, Strasbourg, France.
Hôpitaux Universitaires de Strasbourg · FRInstitut de Cancérologie Strasbourg · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRInternational Space University · FRInserm · FRLaboratoire de Génétique Médicale · FRSorbonne Université · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite recent progress in the field of genetics, sporadic late-onset (> 40 years) cerebellar ataxia (SLOCA) etiology remains frequently elusive, while the optimal diagnostic workup still needs to be determined. We aimed to comprehensively describe the causes of SLOCA and to discuss the relevance of the investigations.

methodsWe included 205 consecutive patients with SLOCA seen in our referral center. Patients were prospectively investigated using exhaustive clinical assessment, biochemical, genetic, electrophysiological, and imaging explorations.

resultsWe established a diagnosis in 135 (66%) patients and reported 26 different causes for SLOCA, the most frequent being multiple system atrophy cerebellar type (MSA-C) (41%). Fifty-one patients (25%) had various causes of SLOCA including immune-mediated diseases such as multiple sclerosis or anti-GAD antibody-mediated ataxia; and other causes, such as alcoholic cerebellar degeneration, superficial siderosis, or Creutzfeldt-Jakob disease. We also identified 11 genetic causes in 20 patients, including SPG7 (n = 4), RFC1-associated CANVAS (n = 3), SLC20A2 (n = 3), very-late-onset Friedreich's ataxia (n = 2), FXTAS (n = 2), SCA3 (n = 1), SCA17 (n = 1), DRPLA (n = 1), MYORG (n = 1), MELAS (n = 1), and a mitochondriopathy (n = 1) that were less severe than MSA-C (p < 0.001). Remaining patients (34%) had idiopathic late-onset cerebellar ataxia which was less severe than MSA-C (p < 0.01).

conclusionOur prospective study provides an exhaustive picture of the etiology of SLOCA and clues regarding yield of investigations and diagnostic workup. Based on our observations, we established a diagnostic algorithm for SLOCA.

Indexed as

Cerebellar AtaxiaMultiple System AtrophySpinocerebellar AtaxiasSpinocerebellar DegenerationsHumansProspective StudiesSodium-Phosphate Cotransporter Proteins, Type IIISLC20A2 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIIBrain MRIGeneticsI123-ioflupane SPECTLate-onset cerebellar ataxiaMultiple system atrophy

Identifiers

PMID35869996
OpenAlexW4286685054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.